Abstract

ObjectiveIn 2010, national guidelines were published in Ireland recommending more sensitive criteria for the diagnosis of Gestational Diabetes Mellitus (GDM). The criteria were based on the 2008 Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Study and were endorsed subsequently by the World Health Organization (WHO). Screening nationally is selective based on risk factors. We examined the impact of the new criteria on hospital trends nationally for GDM over the 10 years 2008–17.Research design and methodsData from three national databases, the Hospital Inpatient Enquiry System (HIPE), National Perinatal Reporting System (NPRS) and the Irish Maternity Indicator System (IMIS), were analyzed using descriptive statistics, analysis of variance, and Poisson loglinear modelling.ResultsThe overall incidence of GDM nationally increased almost five-fold from 3.1% in 2008 to 14.8% in 2017 (p ≤ 0.001). The incidence varied widely across maternity units. In 2008, the incidence varied from 0.4 to 5.9% and in 2017 it varied from 1.9 to 29.4%. There were increased obstetric interventions among women with GDM over the decade, specifically women with GDM having increased cesarean sections (CS) and induction of labor (IOL) (p ≤ 0.001). These trends were significant in large and mid-sized maternity hospitals (p ≤ 0.001). The increase in GDM diagnosis could not be explained by an increase in maternal age nationally over the decade. The data did not include information on other risk factors such as obesity. The increased incidence in GDM diagnosis was accompanied by a decrease in high birthweight ≥ 4.5 kg nationally.ConclusionsWe found adoption of the new criteria for diagnosis of GDM resulted in a major increase in the incidence of GDM rates. Inter-hospital variations increased over the decade, which may be explained by variations in the implementation of the new national guidelines in different maternity units. It is likely to escalate further as compliance with national guidelines improves at all maternity hospitals, with implications for provision and configuration of maternity services. We observed trends that may indicate improvements for women and their offspring, but more research is required to understand patterns of guideline implementation across hospitals and to demonstrate how increased GDM diagnosis will improve clinical outcomes.

Highlights

  • There is a lack of consensus worldwide about screening and testing for Gestational Diabetes Mellitus (GDM)

  • We found adoption of the new criteria for diagnosis of GDM resulted in a major increase in the incidence of GDM rates

  • Inter-hospital variations increased over the decade, which may be explained by variations in the implementation of the new national guidelines in different maternity units

Read more

Summary

Introduction

There is a lack of consensus worldwide about screening and testing for Gestational Diabetes Mellitus (GDM). Screening may be universal or selective based on maternal or fetal risk factors. The risk factors applied may vary and adherence is rarely measured. Testing is usually with an Oral Glucose Tolerance Test (OGTT) at 24–28 weeks gestation but the glucose load administered may be 75 g or 100 g. Testing may be one-step or twostep where a 50 g Glucose Challenge Test preceded the 75 g or 100 g OGTT. Different measurements of maternal plasma glucose may be used for diagnostic purposes. In the Republic of Ireland, maternity services are predominantly hospital-based, with approximately 0.3% of births occurring at home [19]. The hospitals provide public and private maternity care. They vary in size, based on the number of births per annum. Since 2014, there have been no exclusively private maternity hospitals nationally

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call